Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle

References

• PetrovskiKRHeuerCParkinsonTJWilliamsonNBThe incidence and aetiology of clinical bovine mastitis on 14 farms in Northland, New ZealandN Z Vet J200957210911519471330
   PubMed Web of Science ®Google Scholar
• McDougallSAgnewKECursonsRHouXXComptonCRParenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide in dairy cattleJ Dairy Sci200790277978917235155
   PubMed Web of Science ®Google Scholar
• McDougallSPrevalence of clinical mastitis in 38 Waikato dairy herds in early lactationN Z Vet J199947414314916032091
   PubMed Web of Science ®Google Scholar
• McDougallSEfficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cowsN Z Vet J199846622623216032054
   PubMed Web of Science ®Google Scholar
• McDougallSArthurDGBryanMAVermuntJJWeirAMClinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibioticsN Z Vet J200755416117017676080
   PubMed Web of Science ®Google Scholar
• ShumLWMcConnelCSGunnAAHouseJKEnvironmental mastitis in intensive high-producing dairy herds in New South WalesAust Vet J2009871246947519930160
   PubMed Web of Science ®Google Scholar
• PrenafetaASitjaMHolmesMAPatersonGKShort communication: biofilm production characterization of mecA and mecC methicillin-resistant Staphylococcus aureus isolated from bovine milk in Great BritainJ Dairy Sci20149784838484124881796
   PubMed Web of Science ®Google Scholar
• Silveira-FilhoVMLuzISCamposAPAntibiotic resistance and molecular analysis of Staphylococcus aureus isolated from cow’s milk and dairy products in northeast BrazilJ Food Prot201477458359124680069
   PubMed Web of Science ®Google Scholar
• JamaliHRadmehrBIsmailSShort communication: prevalence and antibiotic resistance of Staphylococcus aureus isolated from bovine clinical mastitisJ Dairy Sci20149742226223024534509
   PubMed Web of Science ®Google Scholar
• SzwedaPSchielmannMFrankowskaAKotBZalewskaMAntibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin BJ Vet Med Sci201476335536224212507
   PubMed Web of Science ®Google Scholar
• HulseECLancasterJEThe treatment with nisin of chronic bovine mastitis caused by S. uberis and staphylococciVet Rec1951632947748014867189
   PubMedGoogle Scholar
• OldhamERDaleyMJLysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeuticJ Dairy Sci19917412417541821787188
   PubMed Web of Science ®Google Scholar
• LiLZhangZIsolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattleMol Biol Rep20144195829583824981924
   PubMed Web of Science ®Google Scholar
• DeUKMukherjeeRActivity of cyclooxygenase-2 and nitric oxide in milk leucocytes following intramammary inoculation of a bio-response modifier during bovine Staphylococcus aureus subclinical mastitisVet Res Commun201438320120724844929
   PubMed Web of Science ®Google Scholar
• DemonDBreyneKSchifferGMeyerEShort communication: antimicrobial efficacy of intramammary treatment with a novel biphenomycin compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-induced mouse mastitisJ Dairy Sci201396117082708724054294
   PubMed Web of Science ®Google Scholar
• SterCAllardMBoulangerSExperimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analogJ Dairy Sci20139621000100823245959
   PubMed Web of Science ®Google Scholar
• BouchardDSRaultLBerkovaNLoirYLEvenSInhibition of Staphylococcus aureus invasion into bovine mammary epithelial cells by contact with live Lactobacillus caseiAppl Environ Microbiol201379387788523183972
   PubMed Web of Science ®Google Scholar
• CardozoVFLancherosCANarcisoAMEvaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitisInt J Pharm20144731–2202924979535
   PubMedGoogle Scholar
• FratiniFCasellaSLeonardiMAntibacterial activity of essential oils, their blends and mixtures of their main constituents against some strains supporting livestock mastitisFitoterapia2014961724727086
   PubMed Web of Science ®Google Scholar
• PeriniSPiccoliRHNunesCABruhnFRPCustodioDACCostaGMAntimicrobial activity of essential oils against pathogens isolated from Bovine MastitisJ Nat Prod Plant Resour201442615
   Google Scholar
• MullenKAEAndersonKLWashburnSPEffect of 2 herbal intramammary products on milk quantity and quality compared with conventional and no dry cow therapyJ Dairy Sci20149763509352224731642
   PubMed Web of Science ®Google Scholar
• IosifFNChirilaFNadasGRapunteanSBouariCStudy regarding the sensitivity of staphylococci strains isolated from mastitis cow milk to propolis extracts. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-NapocaVet Med2014711272
   Google Scholar
• SantanaHFBarbosaAAFerreiraSOMantovaniHCBactericidal activity of ethanolic extracts of propolis against Staphylococcus aureus isolated from mastitic cowsWorld J Microbiol Biotechnol201228248549122806843
   PubMed Web of Science ®Google Scholar
• GehringRSmithGWAn overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitisJ Vet Pharmacol Ther200629423724116846460
   PubMed Web of Science ®Google Scholar
• PageSGargSinventorsLuoda Pharma Pty Limited, assigneeMethods of treating microbial infections, including mastitis Patent WO2014121343 A12014814
   Google Scholar
• VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today2007121068107518061887
   PubMed Web of Science ®Google Scholar
• AlhnanMAMurdanSBasitAWEncapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailabilityInt J Pharm20114161556021679756
   PubMed Web of Science ®Google Scholar
• SethiaSSquillanteESolid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methodsInt J Pharm20042721–211015019063
   PubMed Web of Science ®Google Scholar
• ShahzadYSohailSArshadMSHussainTShahSNDevelopment of solid dispersions of artemisinin for transdermal deliveryInt J Pharm2013457119720524084449
   PubMedGoogle Scholar
• CafaggiSRussoECaviglioliGPoloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulationEur J Pharm Sci2008351–2192918598763
   PubMed Web of Science ®Google Scholar
• ChenCXieXLiYInfluence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersionsDrug Dev Ind Pharm201440444145123614831
   PubMed Web of Science ®Google Scholar
• TaupitzTDressmanJBBuchananCMKleinSCyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazoleEur J Pharm Biopharm201383337838723201048
   PubMed Web of Science ®Google Scholar
• ShammaRNBashaMSoluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparationPowder Technol20132370406414
   Google Scholar
• MilinovichGJTrottDJBurrellPCChanges in equine hindgut bacterial populations during oligofructose-induced laminitisEnviron Microbiol20068588589816623745
   PubMed Web of Science ®Google Scholar
• CLSIPerformance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, approved standardWattsJLShryockTRApleyMDThird edition; CLSI M31-A3222nd edWayne, PA, USAClinical and Laboratory Standards Institute2008116
   Google Scholar
• FoxPFMcSweeneyPLHDairy Chemistry and BiochemistryLondonBlackie Academic and Professional Publishers1998
   Google Scholar
• NagyZKBaloghAVajnaBComparison of electrospun and extruded Soluplus(R)-based solid dosage forms of improved dissolutionJ Pharm Sci2012101132233221918982
   PubMed Web of Science ®Google Scholar
• YunFKangAShanJPreparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancementInt J Pharm20144651–243644324576810
   PubMedGoogle Scholar
• MoesJJKoolenSLHuitemaADSchellensJHBeijnenJHNuijenBPharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)Int J Pharm2011420224425021907780
   PubMed Web of Science ®Google Scholar
• GuzmanHRTawaMZhangZCombined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulationsJ Pharm Sci200796102686270217518357
   PubMed Web of Science ®Google Scholar
• RaoSSongYPeddieFEvansAMParticle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugsInt J Nanomedicine201161245125121753876
   PubMed Web of Science ®Google Scholar
• KietzmannMNiedorfFGossellinJTissue distribution of cloxacillin after intramammary administration in the isolated perfused bovine udderBMC Vet Res201064620925913
   PubMed Web of Science ®Google Scholar
• EhingerAMKietzmannMTissue distribution of benzylpenicillin after intramammary administration in the isolated perfused bovine udderJ Vet Pharmacol Ther200023530331011107004
   PubMed Web of Science ®Google Scholar